Encompass Health Corporation (EHC) Income Statement Analysis

See more : Abraxas Petroleum Corporation (AXAS) Income Statement Analysis – Financial Results

Complete financial analysis of Encompass Health Corporation (EHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Encompass Health Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.

You may be interested

Encompass Health Corporation (EHC)

Industry: Medical - Care Facilities

Sector: Healthcare

Website: https://www.encompasshealth.com

About Encompass Health Corporation

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1985
Revenue	4.80B	4.35B	5.12B	4.64B	4.61B	4.28B	3.92B	3.65B	3.12B	2.37B	2.25B	2.13B	2.03B	520.70M	1.91B	1.84B	1.75B	3.00B	3.21B	3.75B	3.96B	4.31B	4.38B	4.20B	4.07B	4.01B	3.02B	2.44B	1.56B	1.13B	482.30M	407.00M	225.50M	180.50M	114.20M	75.00M	45.00M	18.60M	4.50M
Cost of Revenue	3.87B	202.10M	209.30M	200.50M	167.90M	158.70M	149.30M	140.00M	128.70M	111.90M	105.40M	102.40M	1.31B	0.00	1.33B	108.90M	969.80M	1.69B	1.73B	2.46B	2.58B	3.09B	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	348.90M	313.80M	165.60M	135.80M	85.20M	55.70M	33.60M	14.10M	4.10M
Gross Profit	933.50M	4.15B	4.91B	4.44B	4.44B	4.12B	3.77B	3.51B	2.99B	2.26B	2.14B	2.03B	712.50M	520.70M	578.50M	1.73B	782.70M	1.31B	1.48B	1.29B	1.38B	1.22B	4.38B	4.20B	4.07B	4.01B	3.02B	2.44B	1.56B	1.13B	133.40M	93.20M	59.90M	44.70M	29.00M	19.30M	11.40M	4.50M	400.00K
Gross Profit Ratio	19.44%	95.35%	95.91%	95.68%	96.35%	96.29%	96.19%	96.16%	95.87%	95.29%	95.31%	95.20%	35.15%	100.00%	30.27%	94.09%	44.66%	43.80%	46.15%	34.43%	34.80%	28.25%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	27.66%	22.90%	26.56%	24.76%	25.39%	25.73%	25.33%	24.19%	8.89%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	201.70M	2.60B	3.16B	2.92B	2.90B	2.65B	2.40B	2.19B	1.86B	1.34B	1.27B	1.23B	1.25B	327.00M	1.21B	149.90M	186.40M	235.60M	246.18M	289.75M	157.93M	0.00	167.21M	148.02M	149.29M	112.80M	82.76M	66.81M	42.51M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.01B	1.28B	330.10M	717.90M	616.28M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	201.70M	2.60B	3.16B	2.92B	2.90B	2.65B	2.40B	2.19B	1.86B	1.34B	1.27B	1.23B	1.25B	327.00M	197.60M	1.43B	516.50M	953.50M	862.45M	289.75M	157.93M	304.44M	167.21M	148.02M	149.29M	112.80M	82.76M	66.81M	42.51M	37.14M	26.70M	11.00M	5.30M	5.10M	4.90M	3.60M	2.20M	1.80M	1.70M
Other Expenses	0.00	914.00M	941.80M	877.40M	842.30M	2.20M	4.10M	2.90M	5.50M	31.20M	4.50M	8.50M	99.80M	387.70M	378.90M	83.80M	77.50M	148.20M	167.11M	3.52B	4.10B	0.00	2.74B	2.67B	2.54B	2.38B	1.81B	1.59B	1.09B	0.00	36.50M	25.50M	14.70M	11.10M	7.10M	4.00M	2.60M	1.20M	400.00K
Operating Expenses	693.90M	3.52B	4.11B	3.80B	3.74B	3.44B	3.12B	2.86B	2.43B	1.80B	1.68B	1.62B	1.35B	426.60M	305.10M	1.51B	594.00M	1.10B	1.03B	3.52B	4.10B	304.44M	2.91B	2.82B	2.69B	2.49B	1.89B	1.65B	1.13B	873.03M	63.20M	36.50M	20.00M	16.20M	12.00M	7.60M	4.80M	3.00M	2.10M
Cost & Expenses	4.07B	3.72B	4.32B	4.00B	3.91B	3.60B	3.27B	3.00B	2.56B	1.91B	1.79B	1.72B	1.35B	426.60M	1.64B	1.62B	1.56B	2.79B	2.76B	3.52B	4.10B	3.40B	2.91B	2.82B	2.69B	2.49B	1.89B	1.65B	1.13B	873.03M	412.10M	350.30M	185.60M	152.00M	97.20M	63.30M	38.40M	17.10M	6.20M
Interest Income	0.00	175.70M	164.30M	183.70M	159.70M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	143.50M	175.70M	164.60M	184.20M	159.70M	147.30M	154.40M	172.10M	142.90M	109.20M	100.40M	94.10M	119.40M	34.50M	125.80M	159.70M	229.90M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	273.90M	243.60M	219.60M	243.00M	218.70M	199.70M	183.80M	172.60M	139.70M	107.70M	94.70M	82.50M	78.80M	76.40M	70.90M	97.00M	85.30M	166.50M	208.13M	199.49M	200.20M	205.70M	375.27M	360.85M	374.25M	344.59M	250.01M	188.97M	121.20M	75.59M	-36.50M	-25.50M	-14.70M	-11.10M	-7.10M	4.00M	2.60M	1.20M	400.00K
EBITDA	1.02B	873.80M	879.00M	815.20M	911.20M	881.30M	833.20M	823.80M	709.20M	592.00M	553.50M	516.60M	441.10M	406.20M	320.20M	437.40M	273.30M	173.10M	232.60M	488.82M	-8.34M	3.73B	1.85B	3.45B	1.76B	1.86B	1.01B	785.80M	547.81M	330.00M	106.70M	81.50M	49.10M	35.50M	20.00M	15.70M	9.20M	2.70M	-1.30M
EBITDA Ratio	21.34%	20.04%	21.08%	19.48%	20.60%	20.86%	21.57%	22.88%	22.73%	25.92%	25.33%	24.22%	37.77%	33.24%	18.26%	10.41%	19.13%	25.28%	33.22%	13.02%	4.86%	37.60%	42.25%	41.47%	43.16%	46.40%	45.70%	39.92%	35.19%	29.27%	31.76%	20.02%	21.77%	19.67%	17.51%	18.27%	17.56%	11.83%	-35.56%
Operating Income	731.80M	627.90M	822.80M	661.90M	729.70M	681.60M	649.40M	648.80M	554.20M	465.70M	381.90M	413.40M	674.70M	342.20M	273.40M	219.20M	188.70M	212.20M	450.75M	233.12M	-140.43M	913.20M	1.48B	1.38B	1.38B	1.51B	1.13B	783.73M	426.62M	254.41M	70.20M	56.70M	39.90M	28.50M	17.00M	11.70M	6.60M	1.50M	-1.70M
Operating Income Ratio	15.24%	14.44%	16.07%	14.25%	15.85%	15.94%	16.57%	17.79%	17.79%	19.61%	16.99%	19.36%	33.29%	65.72%	14.31%	11.90%	10.77%	7.07%	14.05%	6.21%	-3.55%	21.18%	33.68%	32.87%	33.97%	37.80%	37.41%	32.17%	27.41%	22.57%	14.56%	13.93%	17.69%	15.79%	14.89%	15.60%	14.67%	8.06%	-37.78%
Total Other Income/Expenses	-124.60M	-1.09B	-969.90M	103.80M	-130.20M	-188.40M	-153.00M	-166.80M	-158.60M	-78.80M	-63.60M	-73.40M	-140.70M	-137.90M	-153.40M	-23.70M	-312.80M	-582.60M	-448.89M	-375.12M	-358.36M	-1.28B	-1.64B	-1.81B	-1.15B	-1.25B	-194.80M	-227.50M	-214.30M	-167.15M	-59.40M	-11.70M	-6.00M	-8.40M	-4.50M	-2.80M	-400.00K	-500.00K	300.00K
Income Before Tax	607.20M	450.80M	657.20M	472.60M	562.30M	493.20M	496.40M	482.00M	395.60M	386.90M	395.20M	340.00M	242.90M	50.80M	123.50M	164.70M	-123.60M	-557.90M	-344.79M	-141.99M	-498.79M	-242.14M	433.73M	559.35M	229.92M	267.37M	601.63M	410.49M	142.62M	87.26M	10.80M	45.00M	33.90M	20.10M	12.50M	8.90M	6.20M	1.00M	-1.40M
Income Before Tax Ratio	12.65%	10.37%	12.83%	10.18%	12.21%	11.53%	12.67%	13.22%	12.70%	16.30%	17.59%	15.93%	11.98%	9.76%	6.46%	8.94%	-7.05%	-18.60%	-10.75%	-3.78%	-12.60%	-5.62%	9.90%	13.33%	5.65%	6.67%	19.94%	16.85%	9.16%	7.74%	2.24%	11.06%	15.03%	11.14%	10.95%	11.87%	13.78%	5.38%	-31.11%
Income Tax Expense	132.20M	100.10M	139.60M	103.80M	115.90M	118.90M	160.60M	163.90M	141.90M	110.70M	12.70M	108.60M	37.10M	-736.20M	-3.20M	-70.10M	-322.40M	41.10M	39.79M	11.91M	-42.42M	-55.21M	139.47M	181.81M	66.93M	143.35M	206.15M	140.24M	48.09M	33.84M	4.10M	15.30M	11.50M	7.20M	4.40M	3.20M	2.40M	500.00K	-200.00K
Net Income	352.00M	271.00M	412.20M	284.20M	358.70M	292.30M	256.30M	247.60M	183.10M	222.00M	323.60M	185.00M	208.70M	779.20M	94.80M	252.40M	653.40M	-625.00M	-445.99M	-174.47M	-434.56M	-270.09M	202.39M	278.47M	76.52M	46.56M	330.61M	220.82M	78.95M	53.23M	6.70M	29.70M	22.40M	12.90M	8.10M	5.70M	3.80M	500.00K	-1.50M
Net Income Ratio	7.33%	6.23%	8.05%	6.12%	7.79%	6.83%	6.54%	6.79%	5.88%	9.35%	14.40%	8.67%	10.30%	149.64%	4.96%	13.70%	37.28%	-20.83%	-13.90%	-4.65%	-10.98%	-6.27%	4.62%	6.64%	1.88%	1.16%	10.96%	9.06%	5.07%	4.72%	1.39%	7.30%	9.93%	7.15%	7.09%	7.60%	8.44%	2.69%	-33.33%
EPS	3.54	2.72	4.15	2.87	3.65	2.99	2.73	2.77	2.02	2.46	2.58	1.67	1.91	9.41	0.77	2.73	7.97	-7.86	-5.62	-2.20	-5.49	-3.41	-2.45	-4.70	0.95	0.55	5.22	3.23	3.45	1.75	0.24	1.04	0.79	0.45	0.28	0.20	0.13	0.02	-0.05
EPS Diluted	3.47	2.70	4.11	2.85	3.61	2.93	2.69	2.59	1.91	2.29	2.58	1.67	1.91	8.28	0.77	2.62	7.10	-6.92	-5.60	-2.19	-5.35	-3.31	-2.45	-4.70	0.90	0.55	5.22	3.23	3.45	1.74	0.24	1.04	0.79	0.45	0.28	0.20	0.13	0.02	-0.05
Weighted Avg Shares Out	99.50M	99.20M	99.00M	98.60M	98.00M	97.90M	93.70M	89.10M	89.40M	86.80M	88.10M	94.60M	93.30M	92.80M	88.80M	83.00M	78.70M	79.50M	79.30M	79.28M	79.23M	79.10M	78.10M	77.33M	81.64M	84.29M	79.66M	65.77M	60.99M	30.35M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M
Weighted Avg Shares Out (Dil)	101.30M	100.40M	100.20M	99.80M	99.40M	99.80M	99.30M	99.50M	101.00M	100.70M	102.10M	108.10M	109.20M	108.50M	103.30M	96.40M	92.00M	90.30M	79.60M	79.53M	81.17M	81.70M	83.03M	78.28M	82.91M	86.46M	79.66M	65.77M	60.99M	30.63M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M	28.45M

Encompass Health Announces Date of 2024 Third Quarter Earnings Call

October 10, 2024prnewswire.com

BIRMINGHAM, Ala. , Oct. 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept.

Encompass Health (EHC) Upgraded to Buy: Here's What You Should Know

October 8, 2024zacks.com

Encompass Health (EHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Encompass Health (EHC) Stock Undervalued Right Now?

October 8, 2024zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...

Encompass Health (EHC) is a Top-Ranked Momentum Stock: Should You Buy?

October 7, 2024zacks.com

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Compelling Reasons to Hold on to Encompass Health Stock Right Now

October 4, 2024zacks.com

EHC remains well-poised for growth on the back of improved revenues, an extensive rehabilitation hospital network and sufficient cash-generating abilities.